XML 160 R144.htm IDEA: XBRL DOCUMENT v3.25.0.1
SEGMENT INFORMATION - Narrative (Details) - Product Concentration Risk
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenues | Customer, Top Ten Products      
Segment reporting information      
Concentration risk, percentage 50.00% 48.00% 49.00%
Salix | Xifaxan Branded Products | Revenue from Contract with Customer, Segment Benchmark      
Segment reporting information      
Concentration risk, percentage 85.00%